Ethyl 2-methyl-2-(piperidin-4-yl)propanoate hydrochloride

Catalog No. :
ACIGAR851
CAS No. :
243836-26-2
Molecular Formula :
C11H22ClNO2
Molecular Weight :
235.76

IUPAC Name:Ethyl 2-methyl-2-(piperidin-4-yl)propanoate hydrochloride

Ethyl 2-methyl-2-(piperidin-4-yl)propanoate hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$58.00Login to see priceIn stockInquiry
250mg97%$73.00Login to see priceIn stockIn stock
1g97%$144.00Login to see priceIn stockIn stock
5g97%$689.00Login to see priceIn stockInquiry
10g97%$995.00Login to see priceIn stockInquiry
25g97%$2438.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-methyl-2-(piperidin-4-yl)propanoate hydrochloride
IUPAC NameEthyl 2-methyl-2-(piperidin-4-yl)propanoate hydrochloride
MDL No.MFCD08703276
Molecular FormulaC11H22ClNO2
Molecular Weight235.76
SMILESCC(C1CCNCC1)(C)C(OCC)=O.[H]Cl
InChI KeyLOJQEJZIJAXDQB-UHFFFAOYSA-N
Synonymethyl 2-methyl-2-(piperidin-4-yl)propanoate;ETHYL 2-METHYL-2-(PIPERIDIN-4-YL)PROPANOATE HCL;α,α-dimethyl-4-piperidineacetic acid ethyl ester hydrochloride;4-Piperidineaceticacid, a,a-dimethyl-, ethyl ester, hydrochl...
CAS No.243836-26-2
PubChem CID49759623

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACIGAR851 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIGAR851 route product structure diagram
    ACIGAR851243836-26-2 In Stock
Inquiry

2. ACIGAR851 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIGAR851 route product structure diagram
    ACIGAR851243836-26-2 In Stock
Inquiry

Comments (0)